Coagulation factor VIII replacement therapy
This page covers all Coagulation factor VIII replacement therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Factor VIII.
Targets
Phase 2 pipeline (1)
- FVIII products · Bayer · Hematology
FVIII products replace or supplement the missing or defective clotting factor VIII in the blood to help the blood to clot normally.